Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update.

Int Semin Surg Oncol · 2006 · PMC1586206 · PMID 16981992

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

of borderline significancep = 0.056so close (0.05 < p ≤ 0.1)

There was a 12% statistically non-significant reduction in breast cancer-related deaths in the anastrozole group compared to tamoxifen and a reduction of borderline significance in distant metastases (hazard ratio: 0.84, p = 0.056).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.